SCHEMBL8129299

SCHEMBL8129299

O=C1CCc2cccc([N+](=O)[O-])c2N1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.53
CYP11B2 P19099 1/20 0.53
ALDH1A1 P00352 1/20 0.46
CYP3A4 P08684 1/20 0.46
ALOX15 P16050 1/20 0.46
HSD17B10 Q99714 1/20 0.46
NPC1 O15118 1/20 0.44
MAPK13 O15264 1/20 0.44
MAPK12 P53778 1/20 0.44
MAPK11 Q15759 1/20 0.44
MAPK14 Q16539 1/20 0.44
ACHE P22303 1/20 0.44
KIF11 P52732 1/20 0.43
TDP1 Q9NUW8 2/20 0.41
CRBN Q96SW2 2/20 0.41
DDB1 Q16531 1/20 0.41
GPR35 Q9HC97 1/20 0.40
S100A4 P26447 1/20 0.40
TDP2 O95551 1/20 0.39
CASP7 P55210 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4409786 0.85 AHR (0.54) CYP11B1CYP11B2ALDH1A1CYP3A4ALOX15
SCHEMBL376278 0.76 PNMT (0.47) ALDH1A1CYP3A4ALOX15HSD17B10ACHE
SCHEMBL30163069 0.74 CYP11B1 (0.54) CYP11B1CYP11B2ALDH1A1CYP3A4NPC1
SCHEMBL30417452 0.74 ALDH1A1 (0.47) ALDH1A1ACHETDP1GPR35S100A4
SCHEMBL22868312 0.74 CYP11B1 (0.54) CYP11B1CYP11B2ALDH1A1CYP3A4NPC1
SCHEMBL1119381 0.74 CYP11B1 (0.54) CYP11B1CYP11B2ALDH1A1CYP3A4KIF11
SCHEMBL1137413 0.74 ALDH1A1 (0.47) ALDH1A1ACHETDP1GPR35S100A4
SCHEMBL10840085 0.74 TDP1 (0.42) ALDH1A1CYP3A4ALOX15HSD17B10NPC1
SCHEMBL10400093 0.73 SRC (0.47) ALDH1A1CYP3A4ALOX15HSD17B10ACHE
SCHEMBL3594575 0.73 KIF11 (0.46) NPC1MAPK13MAPK12MAPK11MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2847190-A1 BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF Bayer Pharma Aktiengesellschaft (DE) 2015-03-18 EP disclosed
WO-2013167495-A1 BICYCLICALLY SUBSTITUTED URACILS AND THE USE THEREOF BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2013-11-14 WO disclosed
EP-1054889-A1 NEW OXAZOLIDINONES WITH AZOL-CONTAINING TRICYCLES Bayer Aktiengesellschaft (DE) 2000-11-29 EP disclosed
EP-1049692-A1 NOVEL BICYCLENE-SUBSTITUTED OXAZOLIDINONES Bayer Aktiengesellschaft (DE) 2000-11-08 EP disclosed
WO-1999040094-A1 AGENT FOR SEALING METALLIC GROUND COATS, ESPECIALLY GROUND COATS CONSISTING OF ZINC OR ZINC ALLOYS BAYER AKTIENGESELLSCHAFT (DE) 1999-08-12 WO disclosed
WO-1999037641-A1 NOVEL BICYCLENE-SUBSTITUTED OXAZOLIDINONES BAYER AKTIENGESELLSCHAFT (DE) 1999-07-29 WO disclosed
EP-0275888-B1 Tricyclic benzimidazoles, process for their preparation and use as medicaments BOEHRINGER MANNHEIM GMBH (DE) 1994-04-06 EP disclosed
EP-0275888-A2 Tricyclic benzimidazoles, process for their preparation and use as medicaments Roche Diagnostics GmbH (DE) 1988-07-27 EP disclosed